Literature DB >> 15527737

Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells.

Kristen A Horner1, James E Zadina.   

Abstract

The human neuroblastoma cell line, SH-SY5Y, was used to examine the effects of morphine and the endogenous opioid peptides, endomorphin-1 (EM-1) and endomorphin-2 (EM-2), on mu opioid receptor (MOR) internalization and down-regulation. Treatment for 24 h with EM-1, EM-2 or morphine at 100 nM, 1 microM and 10 microM resulted in a dose-dependent down-regulation of mu receptors. Exposure of cells to 10 microM EM-1 for 2.5, 5 and 24 h resulted in a time-dependent down-regulation of mu receptors. Down-regulation of mu receptors by morphine and EM-1 was blocked by treatment with hypertonic sucrose, consistent with an endocytosis-dependent mechanism. Sensitive cell-surface binding studies with a radiolabeled mu antagonist revealed that morphine was able to induce internalization of mu receptors naturally expressed in SH-SY5Y cells. EM-1 produced a more rapid internalization of mu receptors than morphine, but hypertonic sucrose blocked the internalization induced by each of these agonists. This study demonstrates that, like morphine, the endomorphins down-regulate mu opioid receptors in a dose- and time-dependent manner. This study also demonstrates that morphine, as well as EM-1, can induce rapid, endocytosis-dependent internalization of mu opioid receptors in SH-SY5Y cells. These results may help elucidate the ability of mu agonists to regulate the number and responsiveness of their receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15527737     DOI: 10.1016/j.brainres.2004.07.055

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia.

Authors:  Jadwiga Turchan-Cholewo; Filomena O Dimayuga; Qunxing Ding; Jeffrey N Keller; Kurt F Hauser; Pamela E Knapp; Annadora J Bruce-Keller
Journal:  J Neurosci Res       Date:  2008-07       Impact factor: 4.164

2.  Multiple mechanisms underlying the long duration of action of thienorphine, a novel partial opioid agonist for the treatment of addiction.

Authors:  Gang Yu; Shu-Hui Li; Meng-Xun Cui; Ling-Di Yan; Zheng Yong; Pei-Lan Zhou; Rui-Bin Su; Ze-Hui Gong
Journal:  CNS Neurosci Ther       Date:  2013-12-16       Impact factor: 5.243

3.  Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse.

Authors:  Sophie K Billa; Yan Xia; Jose A Morón
Journal:  Eur J Neurosci       Date:  2010-07-09       Impact factor: 3.386

4.  Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk.

Authors:  Shekher Mohan; Randall L Davis; Udaya DeSilva; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2010-07-07       Impact factor: 3.478

5.  Morphine suppresses intracellular interferon-alpha expression in neuronal cells.

Authors:  Qi Wan; Xu Wang; Yan-Jian Wang; Li Song; Shi-Hong Wang; Wen-Zhe Ho
Journal:  J Neuroimmunol       Date:  2008-06-17       Impact factor: 3.478

6.  Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.

Authors:  Irma Onoprishvili; Eric J Simon
Journal:  Brain Res       Date:  2007-08-16       Impact factor: 3.252

7.  Autoantibodies against opioid or glutamate receptors are associated with changes in morphine reward and physical dependence in mice.

Authors:  Francesca Capone; Walter Adriani; Maria Shumilina; Galina Izykenova; Oleg Granstrem; Svetlana Dambinova; Giovanni Laviola
Journal:  Psychopharmacology (Berl)       Date:  2008-02-12       Impact factor: 4.530

8.  Endogenous morphine in SH-SY5Y cells and the mouse cerebellum.

Authors:  Arnaud Muller; Elise Glattard; Omar Taleb; Véronique Kemmel; Alexis Laux; Monique Miehe; François Delalande; Guy Roussel; Alain Van Dorsselaer; Marie-Hélène Metz-Boutigue; Dominique Aunis; Yannick Goumon
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

9.  Investigating endogenous µ-opioid receptors in human keratinocytes as pharmacological targets using novel fluorescent ligand.

Authors:  Cheryl Leong; Christine Neumann; Srinivas Ramasamy; Bhimsen Rout; Lim Yi Wee; Mei Bigliardi-Qi; Paul L Bigliardi
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.